This website uses cookies. By using the site you are agreeing to our Privacy Policy.

Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.


Main menu starts here.
Skip the main menu to current location in your website.

Current location in your website.
Skip to main contents.


Activities in the healthcare Business

 

Contributing to Human Health and the Progress of Medical Care through the Group's Unique Technologies and Synergies

FUJIFILM has been engaged in producing X-ray film for medical use since the 1930s. As a result of improving our technologies and expanding our expertise, we now cover prevention, diagnosis, and treatment in a comprehensive manner in the healthcare field, and this has become one of the Fujifilm Group's important growth fields.

Note: The article on this page is taken from Sustainability Report 2010.

Activities in the healthcare Business

Comprehensive healthcare company that covers prevention, diagnosis, and treatment

[Photo]Toshio Takahashi Representative Director and Executive Vice President General Manager of healthcare Business Headquarters FUJIFILM Corporation

Toshio Takahashi
Representative Director and
Executive Vice President
General Manager of healthcare
Business Headquarters
FUJIFILM Corporation

The Fujifilm Group regards the healthcare business as one of its important growth fields. Our business provides products and services related to human health and living. Specifically, the Medical Systems Business Division of FUJIFILM focuses on diagnosis, the Life Science Products Division on prevention, Pharmaceutical Products Division and Toyama Chemical on prevention and treatment, and FUJIFILM RI Pharma, which deals with diagnostic radio-pharmaceuticals, on diagnosis and treatment. We are thus using our unique technologies across the whole healthcare field, covering maintenance of health, early detection of disease, and treatment.

FUJIFILM has been closely engaged in medical diagnosis since 1936, soon after the company's inception, when it started to manufacture film for X-ray photography. Its technologies have advanced and expanded significantly, and now include digital X-ray imaging and diagnostic systems, endoscopes, and blood diagnostic systems. The company now provides hospitals with medical image information networking systems so that they can share information on the diagnosis and treatment of patients within their facilities. We have a top share of the market for these systems and our products are now being used as platforms to link medical institutions and to support remote medical care.

Using photographic film technologies for pharmaceuticals and healthcare

In the area of prevention we provide food supplements for health maintenance and anti-aging as well as skincare cosmetics, while in the area of treatment we develop and manufacture radiopharmaceuticals, active pharmaceutical ingredients, and ethical drugs.

We are using a range of technologies built up through our development and manufacture of photographic films in the areas of prevention and treatment. For example the photosensitive layer in a photographic film is made mainly from collagen, which is one of the proteins that form the components of human skin, bones, and ligaments. The technologies we developed for photographic film can be applied to understanding the mechanisms of the human body to use collagen for human health. Nanotechnology, which is an essential technology for controlling fine particles, is used in the preparation of drugs, and anti-oxidation technology used to prevent the color of photographic prints from fading can be used to develop a technology to suppress active oxygen, which is said to cause aging and cancer.

Expansion of the healthcare business

[figure]Expansion of the healthcare business

Expansion of businessPrevention - Diagnosis - Treatment

Enhancing quality of life for everyone

The Fujifilm Group has unique technologies in the healthcare business, which gives us a competitive edge in the market. We can further strengthen our advantage by linking the prevention, diagnosis, and treatment areas through cooperation between the divisions of FUJIFILM and other Group companies.

The Medical Systems Business Division and Fuji Xerox are now cooperating in the use of IT solutions to help hospitals manage their businesses and raise the efficiency of their medical care services. We will help central hospitals and local clinics build effective medical systems through mutual cooperation by networking various types of medical facilities, and we can offer similar support services also to the emerging economies. By combining endoscopes with pharmaceuticals including diagnostic radiopharmaceuticals and antibody pharmaceuticals, we might be able to develop local therapy methods, which allows intensive treatment of only the affected part. These methods will help suppress the side effects of drugs while reducing the burdens imposed on patients.

The Fujifilm Group will continue with its activities in the healthcare business to help people maintain their health by providing them with supplements and other products. While developing new therapies, we will also help them improve the quality of their lives by increasing diagnostic precision and the efficiency of medical care services.

Pharmaceutical Products Business

Continuously expanding the system to develop and sell pharmaceuticals

[Photo]Yuzo Toda Director, Senior Vice President General Manager of Pharmaceutical Products Division healthcare Business Headquarters FUJIFILM Corporation

Yuzo Toda
Director, Senior Vice President
General Manager of
Pharmaceutical Products Division
healthcare Business Headquarters
FUJIFILM Corporation

The life science business of the Fujifilm Group was substantially enhanced with the participation of Toyama Chemical in the Group in 2008, and our understanding of pharmaceutical technologies and business was also greatly improved inside the Group. Engineers from FUJIFILM now also participate in the symposium held annually by Toyama Chemical, and there is active exchange between the R&D sites. Because of the synergy effects inside the Group, we have been successfully developing one or two new drugs every year and the development of promising items, such as the T-705 anti-new influenza agent, is well underway.

In June 2009, FUJIFILM established its Drug Discovery Research Laboratories. While Toyama Chemical specializes in anti-infective agents, the laboratories are engaged in R&D into anti-cancer agents focusing on diagnostic imaging and FTD (*1) technology. Subsequently in November, we established FUJIFILM Pharma to begin the development and marketing of high value-added generic drugs. In the future, we aim to develop this new company into a comprehensive pharmaceuticals company that also develops new drugs.

*1 FUJIFILM's proprietary technology to formulate chemicals by mixing ingredients in a well-balanced way and delivering them to targeted sites in the required form

Medical Systems Business

Focusing on networking diagnostic devices with higher performance

[Photo]Kazuo Nakamura Corporate Vice President, General Manager of Medical Systems Business Division healthcare Business Headquarters FUJIFILM Corporation

Kazuo Nakamura
Corporate Vice President,
General Manager of Medical
Systems Business Division
healthcare Business
Headquarters
FUJIFILM Corporation

The medical systems business is divided into the following four main areas: digital X-ray imaging and diagnostic systems, endoscopes, IT solutions, and blood diagnosis. In recent years, medical institutions have been managing their images and diagnostic information in an increasingly integrated manner, and the linking of the four areas is becoming an important theme in this field of business.

As the basis for information sharing, we provide customers with our SYNAPSE (*2) X-ray image networking systems, which has been highly evaluated by customers. In order to respond to more advanced needs, we have expanded the range of images the system can handle to include 3D images, cardiovascular images, and endoscope images, while starting to provide a system that enables comprehensive reviews of various screening images and diagnostic reports. We are encouraging the use of IT systems in medical facilities to enable them to manage comprehensively a range of hospital information central to medical care and other operations, including medical records on treatment and screening. To further develop this part of our business, we established a Medical Systems Development Center by consolidating our development bases for various devices and systems.

*2 Network system developed for radiography departments to comprehensively manage image information

Note: The article on this page is taken from Sustainability Report 2010.



Footer starts here.

Pages ends here.
Move to top of the page.